Lipella Pharmaceuticals (LIPO) Competitors $2.51 -0.08 (-3.09%) Closing price 03/31/2025 03:59 PM EasternExtended Trading$2.37 -0.15 (-5.78%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock LIPO vs. GOVX, APRE, CSCI, TRIB, BCDA, SNSE, MBRX, BLRX, TLPH, and PMCBShould you be buying Lipella Pharmaceuticals stock or one of its competitors? The main competitors of Lipella Pharmaceuticals include GeoVax Labs (GOVX), Aprea Therapeutics (APRE), COSCIENS Biopharma (CSCI), Trinity Biotech (TRIB), BioCardia (BCDA), Sensei Biotherapeutics (SNSE), Moleculin Biotech (MBRX), BioLineRx (BLRX), Talphera (TLPH), and PharmaCyte Biotech (PMCB). These companies are all part of the "pharmaceutical products" industry. Lipella Pharmaceuticals vs. GeoVax Labs Aprea Therapeutics COSCIENS Biopharma Trinity Biotech BioCardia Sensei Biotherapeutics Moleculin Biotech BioLineRx Talphera PharmaCyte Biotech GeoVax Labs (NASDAQ:GOVX) and Lipella Pharmaceuticals (NASDAQ:LIPO) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, dividends, media sentiment, valuation and community ranking. Does the media prefer GOVX or LIPO? In the previous week, GeoVax Labs had 11 more articles in the media than Lipella Pharmaceuticals. MarketBeat recorded 15 mentions for GeoVax Labs and 4 mentions for Lipella Pharmaceuticals. Lipella Pharmaceuticals' average media sentiment score of 1.09 beat GeoVax Labs' score of 0.58 indicating that Lipella Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GeoVax Labs 1 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Lipella Pharmaceuticals 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is GOVX or LIPO more profitable? GeoVax Labs has a net margin of 0.00% compared to Lipella Pharmaceuticals' net margin of -882.82%. Lipella Pharmaceuticals' return on equity of -192.33% beat GeoVax Labs' return on equity.Company Net Margins Return on Equity Return on Assets GeoVax LabsN/A -809.87% -349.34% Lipella Pharmaceuticals -882.82%-192.33%-154.24% Which has preferable valuation and earnings, GOVX or LIPO? Lipella Pharmaceuticals has lower revenue, but higher earnings than GeoVax Labs. Lipella Pharmaceuticals is trading at a lower price-to-earnings ratio than GeoVax Labs, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGeoVax Labs$3.09M3.24-$25.97M-$5.67-0.19Lipella Pharmaceuticals$483.53K6.28-$4.62M-$4.72-0.53 Which has more risk and volatility, GOVX or LIPO? GeoVax Labs has a beta of 3.06, suggesting that its share price is 206% more volatile than the S&P 500. Comparatively, Lipella Pharmaceuticals has a beta of 0.13, suggesting that its share price is 87% less volatile than the S&P 500. Do analysts recommend GOVX or LIPO? GeoVax Labs currently has a consensus target price of $14.20, indicating a potential upside of 1,239.62%. Lipella Pharmaceuticals has a consensus target price of $16.00, indicating a potential upside of 537.45%. Given GeoVax Labs' stronger consensus rating and higher probable upside, analysts clearly believe GeoVax Labs is more favorable than Lipella Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GeoVax Labs 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 2 Strong Buy rating(s) 3.29Lipella Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals believe in GOVX or LIPO? 6.1% of GeoVax Labs shares are held by institutional investors. Comparatively, 74.3% of Lipella Pharmaceuticals shares are held by institutional investors. 5.7% of GeoVax Labs shares are held by company insiders. Comparatively, 32.1% of Lipella Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the MarketBeat Community favor GOVX or LIPO? GeoVax Labs received 25 more outperform votes than Lipella Pharmaceuticals when rated by MarketBeat users. However, 100.00% of users gave Lipella Pharmaceuticals an outperform vote while only 96.30% of users gave GeoVax Labs an outperform vote. CompanyUnderperformOutperformGeoVax LabsOutperform Votes2696.30% Underperform Votes13.70%Lipella PharmaceuticalsOutperform Votes1100.00% Underperform VotesNo Votes SummaryGeoVax Labs beats Lipella Pharmaceuticals on 10 of the 19 factors compared between the two stocks. Remove Ads Get Lipella Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for LIPO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LIPO vs. The Competition Export to ExcelMetricLipella PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.13M$6.89B$5.63B$7.79BDividend YieldN/A2.81%5.37%4.04%P/E Ratio-0.597.4223.6118.68Price / Sales6.28207.04373.3989.80Price / CashN/A65.6738.1734.64Price / Book0.586.206.734.12Net Income-$4.62M$142.11M$3.20B$247.10M7 Day Performance0.40%-7.28%-5.33%-3.82%1 Month Performance-14.33%-10.45%-0.40%-6.61%1 Year Performance-54.21%-12.86%7.89%-1.67% Lipella Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LIPOLipella Pharmaceuticals3.3515 of 5 stars$2.51-3.1%$16.00+537.5%-54.2%$3.13M$483,533.00-0.594Earnings ReportNews CoveragePositive NewsGOVXGeoVax Labs3.4272 of 5 stars$1.40+6.9%$14.20+914.3%-47.0%$12.36M$3.09M0.0010Earnings ReportShort Interest ↓Analyst RevisionAPREAprea Therapeutics2.8328 of 5 stars$2.26-5.4%$15.50+585.8%-69.5%$12.28M$580,000.00-0.807Earnings ReportShort Interest ↑News CoverageGap UpCSCICOSCIENS BiopharmaN/A$3.22+0.6%N/AN/A$12.16M$7.60M-0.2720High Trading VolumeTRIBTrinity Biotech1.5181 of 5 stars$0.66-6.1%N/A-72.1%$12.00M$59.13M-0.29480Upcoming EarningsAnalyst ForecastBCDABioCardia2.8835 of 5 stars$2.60-2.3%$25.00+861.5%-58.4%$11.92M$71,000.00-0.6240Earnings ReportNews CoverageGap DownSNSESensei Biotherapeutics4.5545 of 5 stars$0.46-5.2%$4.33+832.7%-62.5%$11.69MN/A-0.3940Earnings ReportShort Interest ↓Positive NewsGap DownMBRXMoleculin Biotech2.8873 of 5 stars$1.06-2.8%$18.67+1,661.0%-83.6%$11.51MN/A0.0020Gap DownBLRXBioLineRx2.6257 of 5 stars$3.42-4.5%$360.00+10,426.3%-93.4%$11.39M$21.99M-0.3940Analyst ForecastNews CoverageGap DownTLPHTalphera2.1377 of 5 stars$0.64+0.7%$4.33+578.0%-51.9%$10.88M$281,000.00-0.9319Earnings ReportShort Interest ↑News CoveragePMCBPharmaCyte Biotech1.3593 of 5 stars$1.57-0.6%N/A-47.3%$10.85MN/A2.964Short Interest ↑Positive News Remove Ads Related Companies and Tools Related Companies GOVX Competitors APRE Competitors CSCI Competitors TRIB Competitors BCDA Competitors SNSE Competitors MBRX Competitors BLRX Competitors TLPH Competitors PMCB Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LIPO) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredLive Footage From Elon Musk’s “Area 51”What’s happening inside this nondescript building in South Memphis is so incredible… That Elon’s competitor...Brownstone Research | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | Sponsored“Massive Financial Reset Is Coming”The U.S. markets will see a massive reset, beginning days from now. But the "reset" isn't what you might ex...InvestorPlace | SponsoredGold Hits $3,000… Here’s How You Can Get More for Under $20With gold surging to record highs, currently trading above $3,000 an ounce, and central banks aggressively sto...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lipella Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lipella Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LIPO Stock Free LIPO Stock Alerts